Schroth, W., Winter, S., Mürdter, T., Schaeffeler, E., Eccles, D., Eccles, B., . . . Brauch, H. (2017). Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen. Front Pharmacol.
استشهاد بنمط شيكاغوSchroth, Werner, et al. "Improved Prediction of Endoxifen Metabolism By CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen." Front Pharmacol 2017.
MLA استشهادSchroth, Werner, et al. "Improved Prediction of Endoxifen Metabolism By CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen." Front Pharmacol 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.